Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Equities
2315
CNE100005D27
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.47 CNY | +0.67% | -4.23% | -37.65% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.65% | 382M | |
+21.28% | 46.93B | |
+37.46% | 39.08B | |
-8.39% | 38.48B | |
+30.12% | 31.01B | |
-12.26% | 26.14B | |
+11.07% | 25.88B | |
+35.07% | 12.53B | |
-6.32% | 11.36B | |
-12.40% | 10.65B |
- Stock Market
- Equities
- 2315 Stock
- News Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Biocytogen Pharmaceuticals' RenMab Platform Technology Gets Chinese Patent